Integra Lifesciences Holdings (IART) Raw Materials (2010 - 2017)

Integra Lifesciences Holdings (IART) reported Raw Materials of $48.4 million for Q3 2017, up 23.2% sequentially from $39.2 million in Q4 2016.

Integra Lifesciences Holdings (IART) Raw Materials (2010 - 2017) Analysis & Trends

Integra Lifesciences Holdings (IART) has 7 years of Raw Materials data on file, last reported at $48.4 million in Q3 2017.

  • For the quarter ending Q3 2017, Raw Materials changed N/A year-over-year to $48.4 million; the trailing twelve-month figure through Sep 2017 stood at $48.4 million (changed N/A YoY), and the FY2016 full-year result was $39.2 million, changed N/A from the prior year.
  • Raw Materials climbed to $48.4 million in Q3 2017, from $39.2 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $48.4 million in Q3 2017 to a low of $36.5 million in Q4 2014.
  • A 4-year average of $41.1 million and a median of $39.7 million in 2015 frame the typical range for Raw Materials.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.67 Bn 176.38 Bn 6.27 Bn
2 Stryker 128.91 Bn 126.03 Bn 3.81 Bn
3 Medtronic 108.84 Bn 99.62 Bn 6.41 Bn
4 Boston Scientific 68.57 Bn 67.12 Bn 3.61 Bn
5 Edwards Lifesciences 48.68 Bn 45.01 Bn 1.29 Bn
6 Dexcom 28.42 Bn 27.31 Bn 750.30 Mn
7 GE HealthCare Technologies 28.38 Bn 26.09 Bn 1.98 Bn
8 Smith & Nephew 26.94 Bn 26.36 Bn -
9 Koninklijke Philips 25.50 Bn 22.38 Bn 2.07 Bn
10 Integra Lifesciences Holdings 1.53 Bn 1.26 Bn 216.98 Mn

Historic Data

Download Data
DateValue
Sep 30, 2017 48.35 Mn
Dec 31, 2016 39.25 Mn
Jun 30, 2015 40.22 Mn
Dec 31, 2014 36.47 Mn
Jun 30, 2012 28.40 Mn
Mar 31, 2012 27.23 Mn
Dec 31, 2011 28.22 Mn
Sep 30, 2011 29.69 Mn
Jun 30, 2011 29.95 Mn
Dec 31, 2010 27.88 Mn